The AMPK-SIRT1 Axis: Redefining Type 2 Diabetes Mellitus Management DOI
Mighty Kgalalelo Kemelo,

Phillip Moseki

Опубликована: Янв. 1, 2024

Язык: Английский

The Role of Fenugreek in the Management of Type 2 Diabetes DOI Open Access

Melina Haxhiraj,

Kenneth White, Cassandra Terry

и другие.

International Journal of Molecular Sciences, Год журнала: 2024, Номер 25(13), С. 6987 - 6987

Опубликована: Июнь 26, 2024

The number of people diagnosed with type 2 diabetes is on the increase worldwide. Of growing concern, prevalence in children and youths increasing rapidly mirrors burden childhood obesity. There are many risk factors associated condition; some due to lifestyle, but beyond our control, such as genetics. an urgent need develop better therapeutics for prevention management this complex condition since current medications often cause unwanted side effects, poorly managed can result onset related comorbidities. Naturally derived compounds have gained momentum preventing managing several conditions, including diabetes. Here, we provide update benefits limitations fenugreek its components a therapeutic diabetes, bioavailability interaction microbiome.

Язык: Английский

Процитировано

6

Diabetes Technology in People with Type 2 Diabetes: Novel Indications DOI
Shubham Agarwal, Rodolfo J. Galindo,

A. Shah

и другие.

Current Diabetes Reports, Год журнала: 2024, Номер 24(5), С. 85 - 95

Опубликована: Фев. 29, 2024

Язык: Английский

Процитировано

5

Efficacy of long‐term low carbohydrate diets for patients with type 2 diabetes: A systematic review and meta‐analysis DOI Creative Commons
Takahiro Ichikawa, Hiroshi Okada, Junya Hironaka

и другие.

Journal of Diabetes Investigation, Год журнала: 2024, Номер 15(10), С. 1410 - 1421

Опубликована: Июль 24, 2024

Efficacy of long-term low-carbohydrate diets (LCD) to improve glycemic management for type 2 diabetes remains controversial. Thus, we investigated the association between LCD and control in individuals with diabetes.

Язык: Английский

Процитировано

5

Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy DOI
Andrew J. Barkmeier, Jeph Herrin,

Kavya Swarna

и другие.

Ophthalmology Retina, Год журнала: 2024, Номер 8(10), С. 943 - 952

Опубликована: Май 11, 2024

Язык: Английский

Процитировано

4

The AMPK-SIRT1 Axis: Redefining type 2 diabetes mellitus management DOI Creative Commons
Mighty Kgalalelo Kemelo,

Phillip Moseki

Results in Chemistry, Год журнала: 2025, Номер 14, С. 102139 - 102139

Опубликована: Фев. 19, 2025

Язык: Английский

Процитировано

0

Maximising the potential of type 2 diabetes remission: scale up and sustainability considerations from the DiRECT-Aus implementation trial DOI
Nilakshi Gunatillaka, Jenny Advocat, Lauren Ball

и другие.

Australian Journal of Primary Health, Год журнала: 2025, Номер 31(2)

Опубликована: Март 3, 2025

Background Approximately 500 million people worldwide live with type 2 diabetes mellitus. The UK's 'Diabetes Remission Clinical Trial' (DiRECT) is a potential novel method for care. An Australian trial of DiRECT (DiRECT-Aus) showed that 56% participants achieved remission at 12months. We explored the experiences patients, clinicians and partners involved in DiRECT-Aus to ascertain acceptability feasibility DiRECT-Aus, as well factors influencing implementation, inform recommendations sustainable scale up into mainstream primary Methods This qualitative implementation research conducted within constructivist paradigm semi-structured interviews key stakeholders. Data analysis followed an inductive thematic approach, informed by Consolidated Framework Implementation Research. Results Patients (n =14), general practitioners =3), practice nurses =6), dietitians =7) =5) were interviewed. identified four core components are essential up. They were: (1) access very low-energy diet products; (2) high frequency contact dietitian; (3) dietitian's clinical knowledge patient-centred practice; (4) absence financial costs patients. Several additional could support suggested funding models described. Conclusions study concludes was acceptable feasible patients clinicians.

Язык: Английский

Процитировано

0

The Protective Effect of Curcumin on the Diabetic Uterus: Quantitative and Qualitative Evaluation DOI
A. Mutlu, Kıymet Kübra Tüfekci̇, Süleyman Kaplan

и другие.

Tissue and Cell, Год журнала: 2025, Номер 95, С. 102852 - 102852

Опубликована: Март 8, 2025

Язык: Английский

Процитировано

0

Role of γ-Aminobutyric Acid (GABA) as an Inhibitory Neurotransmitter in Diabetes Management: Mechanisms and Therapeutic Implications DOI Creative Commons
Hassan Barakat, Thamer Aljutaily

Biomolecules, Год журнала: 2025, Номер 15(3), С. 399 - 399

Опубликована: Март 11, 2025

GABA (γ-Aminobutyric Acid), a well-established inhibitory neurotransmitter in the central nervous system, has garnered considerable interest for its potential role diabetes management, particularly due to presence pancreatic islets. This review aims explore therapeutic of management and mechanisms antidiabetic effects. Relevant studies were searched across databases such as PubMed ScienceDirect, applying strict eligibility criteria focused on administration methods diabetic models. The collective results showed that models resulted remarkable enhancements glucose insulin homeostasis, favorable modifications lipid profiles, amelioration dysfunctions neural, hepatic, renal, cardiac systems. findings from literature demonstrated GABAergic signaling within tissues can significantly contribute stimulation β cell proliferation through facilitation sustained trans-differentiation process, wherein glucagon-secreting α cells are converted into insulin-secreting β-like cells. In addition, activated trigger initiation PI3K/AKT pathway tissues, leading improved maintained homeostasis. further function hepatic promoting effects expression genes related gluconeogenesis lipogenesis. Moreover, may enhance gut microbiota diversity by attenuating inflammation, attributable anti-inflammatory immunomodulatory properties. Furthermore, neuroprotective play significant ameliorating neural disorders associated with facilitating substantial reduction neuronal apoptosis. conclusion, emerges promising candidate an agent; however, research is highly encouraged develop rigorously designed framework comprehensively identifies optimizes appropriate dosages intervention effectively managing combating diabetes.

Язык: Английский

Процитировано

0

Prise en charge périopératoire des patients diabétiques DOI Creative Commons

Gaëlle Cheisson

Le Praticien en Anesthésie Réanimation, Год журнала: 2025, Номер unknown

Опубликована: Март 1, 2025

Процитировано

0

The Association Between Health Belief Model Components and Self-Care Practices Among Black/African American Men with Type 2 Diabetes DOI Open Access
Jeong-Hui Park, Ledric D. Sherman, Matthew Lee Smith

и другие.

International Journal of Environmental Research and Public Health, Год журнала: 2025, Номер 22(3), С. 414 - 414

Опубликована: Март 12, 2025

This study investigates the impact of Health Belief Model (HBM) constructs on self-care behaviors among Black/African American men with Type 2 Diabetes (T2D). A cross-sectional survey was conducted from February to June 2024, involving 1225 aged 21 years or older who self-reported a T2D diagnosis. The included HBM constructs, and measured using established scales. Statistical analyses, including multiple linear regression, were performed assess relationships between components practices, adjusted by demographic factors such as age, education, income. found that self-efficacy strongest predictor across all domains (β = 0.055, p < 0.001). Perceived susceptibility positively associated healthful eating 0.042, 0.038), glucose monitoring 0.117, 0.001), foot care 0.140, severity linked diet adherence 0.015, 0.001) 0.028, barriers negatively -0.047, However, perceived benefits did not significantly overall 0.001, 0.893). Self-efficacy, susceptibility, significant predictors T2D. In particular, interventions aimed at enhancing self-efficacy, addressing barriers, promoting awareness diabetes risks may improve management in this population.

Язык: Английский

Процитировано

0